We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ONTO:NYSEOnto Innovation Inc. Analysis

Data as of 2026-04-22 - not real-time

$294.74

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Onto Innovation is riding a strong bullish trend, with the 20‑day SMA (≈242) comfortably above the 50‑day (≈222) and 200‑day (≈159) averages, and a bullish MACD histogram (+5.98) confirming upward momentum. The RSI sits at 74.9, flagging an overbought condition that could prompt a short‑term pullback, while volume is on an increasing trajectory, supporting the current price rally toward the 52‑week high of $301. The stock’s beta of 2.59 and 30‑day volatility of 64% signal pronounced price swings, and the PE ratio of 105 dwarfs the industry average of 37, indicating that the market has priced in substantial growth expectations. However, a discounted cash‑flow model places fair value at $80.6, suggesting a significant valuation gap, though analyst consensus remains strongly positive with a median target of $325 and a forward PE of 32.
Strategic developments are bolstering the outlook: a minority equity investment and partnership with Rigaku to advance hybrid metrology solutions could unlock new revenue streams, aligning with the company’s forward EPS forecast of $9.16 versus trailing $2.79. The balance sheet is solid, featuring $639 M in cash against $17.5 M of debt, and free cash flow of $237 M, providing ample runway for R&D and acquisitions. While the lack of dividend underscores a growth‑oriented capital allocation, the combination of high margins, expanding cash generation, and industry tailwinds in semiconductor equipment positions Onto Innovation as a high‑conviction growth play, albeit at a premium price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Bullish MACD but near 52‑week high
  • Potential short‑term profit‑taking

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strategic Rigaku partnership expanding hybrid metrology
  • Strong forward earnings growth (forward EPS $9.16)
  • Analyst consensus strong‑buy with upside to $325

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term semiconductor equipment demand
  • Robust cash generation and low debt
  • Valuation premium relative to DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin13.60%
P/E Ratio105.6
ROE6.79%
ROA5.93%
Debt/Equity0.83
P/B Ratio7.0
Op. Cash Flow$328.3M
Free Cash Flow$237.4M
Industry P/E37.4

Technical Analysis

TrendBullish
RSI74.9
Support$188.28
Resistance$301.00
MA 20$242.37
MA 50$221.87
MA 200$159.22
MACDBullish
VolumeIncreasing
Fear & Greed Index86.71

Valuation

Fair Value$80.61
Target Price$334.29
Upside/Downside13.42%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.59
Volatility64.37%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.